LFG
APYX icon

Larson Financial Group’s Apyx Medical APYX Stock Holding History

Larson Financial Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,982
Closed -$12.8K – 3470
2025
Q3 		$12.8K Buy
+5,982
New +$12.7K ﹤0.01% 1893

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Larson Financial Group's APYX Position: Q4 2025 in Review

Larson Financial Group sold out of Apyx Medical (APYX) in Q4 2025, closing a stake of 5,982 shares — an estimated $12.8K sold.

Larson Financial Group first reported a position in APYX in Q3 2025 and held it in 1 quarter. The position peaked at $12.8K in Q3 2025. 59 funds tracked by Wall St. Rank hold APYX as of Q4 2025.

  • Larson Financial Group reported no remaining Apyx Medical position as of Q4 2025 after selling out during the quarter.
  • Larson Financial Group sold 5,982 Apyx Medical shares in Q4 2025, an estimated $12.8K.
  • Larson Financial Group first reported a position in Apyx Medical in Q3 2025 and held it in 1 quarter.
  • Larson Financial Group's Apyx Medical position peaked at $12.8K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2025.

Based on Larson Financial Group's 13F filing for Q4 2025, filed 6 Feb 2026.